Differential regulation of a fibroblast growth factor-binding protein by receptor-selective analogs of retinoic acid

Biochemical Pharmacology

Volumn 60, Issue 11, 2000, Pages 1677-1684

  Boyle, Bryan J ^a   Harris, Violaine K ^a   Liaudet Coopman, Emmanuelle D E ^a   Riegel, Anna T ^a   Wellstein, Anton ^a  

^a GEORGETOWN UNIVERSITY   (United States)

Author keywords

Angiogenesis; FGF; FGF BP; RAR; Retinoids; RXR

Indexed keywords

6 [1 (5,6,7,8 TETRAHYDRO 3,5,5,8,8 PENTAMETHYL 2 NAPHTHYL)CYCLOPROPYL]NICOTINIC ACID; BINDING PROTEIN; FIBROBLAST GROWTH FACTOR BINDING PROTEIN; LG 100815; MESSENGER RNA; RETINOIC ACID DERIVATIVE; RETINOIC ACID RECEPTOR; RETINOID X RECEPTOR; UNCLASSIFIED DRUG;

ANGIOGENESIS; ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; DRUG POTENTIATION; HUMAN; HUMAN CELL; IC 50; PRIORITY JOURNAL; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; TUMOR GROWTH;

EID: 0034564111     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(00)00507-4     Document Type: Article

References (29)

1. Retinoids as preventive and therapeutic anticancer agents (Part II)
2. Retinoids as preventive and therapeutic anticancer agents (Part I)
3. Suppression of squamous cell carcinoma growth and differentiation by retinoids
4. 13-cis-Retinoic acid plus interferon-α2a in locally advanced squamous cell carcinoma of the cervix
5. Retinoids in cancer chemoprevention
6. Active cancer therapy combining 13-cis-retinoic acid with interferon-α
7. Retinoids and chemoprevention: Clinical and basic studies
8. Retinoids in cancer treatment
9. Molecular epidemiology and retinoid chemoprevention of head and neck cancer
10. Effect of 13-cis-retinoic acid with neoadjuvant chemotherapy in patients with squamous cervical carcinoma
11. A decade of molecular biology of retinoic acid receptors
12. Design and synthesis of potent retinoid X receptor selective ligands that induce apoptosis in leukemia cells
13. Chemoprevention of mammary carcinoma by LGD1069 (Targretin): An RXR-selective ligand
14. Initial clinical trial of a selective retinoid X receptor ligand, LGD1069
15. Retinoids selective for retinoid X receptor response pathways
16. Identification of a retinoic acid receptor α subtype specific agonist
17. In vivo inhibition of angiogenesis and induction of apoptosis by retinoic acid in squamous cell carcinoma
18. Characterization and molecular cloning of a putative binding protein for heparin-binding growth factors
19. Potent and specific inhibition of mammalian histone deacetylase both in vivo and in vitro by trichostatin A
20. A secreted FGF-binding protein can serve as the angiogenic switch for human cancer
21. Tumor growth and angiogenesis induced by a secreted binding protein for fibroblast growth factors
22. Regulation of gene expression of a binding protein for fibroblast growth factor by retinoic acid
23. Phorbol ester-induced transcription of a FGF-binding protein is modulated by a complex interplay of positive and negative regulatory promoter elements
24. Homodimer formation of retinoid X receptor induced by 9-cis retinoic acid
25. All-trans-retinoic acid inhibits Jun N-terminal kinase by increasing dual-specificity phosphatase activity
26. A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors
27. Interactions controlling the assembly of nuclear receptor heterodimers and co-activators
28. Modulation by retinoic acid (RA) of squamous cell differentiation, cellular RA binding proteins and nuclear RA receptors in human head and neck squamous cell carcinoma cell lines
29. The RXR heterodimers and orphan receptors